These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32737241)

  • 1. July-August 2020 Issue.
    Levy R
    PDA J Pharm Sci Technol; 2020; 74(4):367. PubMed ID: 32737241
    [No Abstract]   [Full Text] [Related]  

  • 2. Quality Assurance and Quality Control, Part 2.
    Akers MJ
    Int J Pharm Compd; 2015; 19(3):215-21. PubMed ID: 26714362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A practical discussion of risk management for manufacturing of pharmaceutical products.
    Mollah AH; Baseman HS; Long M; Rathore AS
    PDA J Pharm Sci Technol; 2014; 68(3):271-80. PubMed ID: 25188348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial endotoxin requirements for dry powder inhalants and their excipients: are they critical quality attributes?
    Cundell AM
    PDA J Pharm Sci Technol; 2014; 68(5):386-93. PubMed ID: 25336414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Top ten hot topics in parenteral science and technology.
    Akers MJ; Nail SL; Saffell-Clemmer W
    PDA J Pharm Sci Technol; 2007; 61(5):337-61. PubMed ID: 18047174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving Forward towards Standardized Analytical Methods for Extractables and Leachables Profiling Studies.
    Jenke D
    PDA J Pharm Sci Technol; 2015; 69(4):471-6. PubMed ID: 26242784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dry-heat Depyrogenation Ovens for Pharmaceutical Compounding Facilities.
    Weller T; Kragseth R; Dullinger R; Illum H; Perry A
    Int J Pharm Compd; 2015; 19(3):182-92. PubMed ID: 26714359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contamination Control.
    Akers MJ
    Int J Pharm Compd; 2015; 19(3):232-8. PubMed ID: 26714364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sterile Product Packaging and Delivery Systems.
    Akers MJ
    Int J Pharm Compd; 2015; 19(6):491-500. PubMed ID: 26891564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategies.
    Barber C; Antonucci V; Baumann JC; Brown R; Covey-Crump E; Elder D; Elliott E; Fennell JW; Gallou F; Ide ND; Jordine G; Kallemeyn JM; Lauwers D; Looker AR; Lovelle LE; McLaughlin M; Molzahn R; Ott M; Schils D; Oestrich RS; Stevenson N; Talavera P; Teasdale A; Urquhart MW; Varie DL; Welch D
    Regul Toxicol Pharmacol; 2017 Nov; 90():22-28. PubMed ID: 28822875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Best practices for extractables and leachables in orally inhaled and nasal drug products: an overview of the PQRI recommendations.
    Norwood DL; Paskiet D; Ruberto M; Feinberg T; Schroeder A; Poochikian G; Wang Q; Deng TJ; DeGrazio F; Munos MK; Nagao LM
    Pharm Res; 2008 Apr; 25(4):727-39. PubMed ID: 18183477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive approach for the determination of extractable and leachable metals in pharmaceutical products by inductively-coupled plasma.
    Zuccarello DJ; Murphy MP; Meyer RF; Winslow PA
    PDA J Pharm Sci Technol; 2009; 63(4):339-52. PubMed ID: 20088247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of portable devices for medicine quality screening: Lessons learnt, recommendations for implementation, and future priorities.
    Caillet C; Vickers S; Vidhamaly V; Boutsamay K; Boupha P; Zambrzycki S; Luangasanatip N; Lubell Y; Fernández FM; Newton PN
    PLoS Med; 2021 Sep; 18(9):e1003747. PubMed ID: 34591861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous and Effective Microbiological Air Monitoring in Critical Environments: A Comparison of Analytical Methodologies.
    Dalmaso G; Campanella A; Lazzeri P
    PDA J Pharm Sci Technol; 2020; 74(4):446-455. PubMed ID: 32060221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extractables Screening of Polypropylene Resins Used in Pharmaceutical Packaging for Safety Hazards.
    Jenke D
    PDA J Pharm Sci Technol; 2017; 71(5):346-367. PubMed ID: 28512176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of biopharmaceutical market-appropriate plastic syringe barrel for extractables.
    DeGrazio F; Runkle J; Smythe J; Miller A
    PDA J Pharm Sci Technol; 2009; 63(4):360-7. PubMed ID: 20088249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory and quality considerations for continuous manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Allison G; Cain YT; Cooney C; Garcia T; Bizjak TG; Holte O; Jagota N; Komas B; Korakianiti E; Kourti D; Madurawe R; Morefield E; Montgomery F; Nasr M; Randolph W; Robert JL; Rudd D; Zezza D
    J Pharm Sci; 2015 Mar; 104(3):803-12. PubMed ID: 25830179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contamination of pharmaceutical products.
    Flaum I
    J Pharm Sci; 1978 Jan; 67(1):1-11. PubMed ID: 619093
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of thermal desorption GC-MS to characterize packaging materials for potential extractables.
    Zweiben C; Shaw AJ
    PDA J Pharm Sci Technol; 2009; 63(4):353-9. PubMed ID: 20088248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Assessment Approach to Microbiological Controls of Cell Therapies.
    Cundell T; Drummond S; Ford I; Reber D; Singer D;
    PDA J Pharm Sci Technol; 2020; 74(2):229-248. PubMed ID: 31941793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.